Members Sign In
Members Sign InWe are thrilled to be able to let you know that Pharmac have confirmed the decision to fund continuous glucose monitors and widen access to insulin pumps and consumables from 1 October 2024. We know that this decision is the result of a considerable amount of work from so many people and we thank you all for your input over many years. This is a momentous event for people and whānau with T1D in Aotearoa and certainly a day to celebrate.
More Info6th Asia Pacific Prader-Willi Syndrome Conference being held in Sydney, Australia, August 30th-31st.
More InfoFREE Online programme held over 20 weeks. Eight weekly 30 minute webinars and eight weekly 30 minute case/discussion/mentoring sessions. Start date May 13th.
More InfoUpdated changes to medicines list - RN prescribers in primary health and specialty teams Registered Nurse (RN) prescribers use advanced knowledge and skills within a collaborative team environment to enable equitable access to care and medicines. The Council is delighted to announce the medicines list for RN prescribers in primary health and specialty teams has been updated as per the Director-General of Health's latest gazette notice, published 23 March 2022.
More InfoFrom 8 November 2018 appropriately qualified nurse practitioners and registered nurses, working within their scope of practice, will be able to carry out a fitness to drive assessment.
More InfoUpdated primary care guidance on the management of type 2 diabetes brings New Zealand in line with international best practice. Today, the New Zealand Society for the Study of Diabetes (NZSSD) launched up-to-date guidance on the management of type 2 diabetes for primary care practitioners. The NZSSD took the initiative to update the guidance with the support of the Ministry of Health. Dr Helen Snell, President of NZSSD says, “The update is timely as it is almost a decade since the last guidance was released in 2012, and clinical guidance on the appropriate use of the ‘new’ diabetes medicines being funded by PHARMAC from 1st February was required.” Currently, approximately 250,000 people are living with diabetes in New Zealand and Dr Snell adds that "the intent of the updated clinical guidance is to increase the number of people with type 2 diabetes in New Zealand who reach their treatment targets.
More InfoLONG AWAITED NEW MEDICINES FOR TYPE 2 DIABETES TO BE FUNDED FROM 1 FEBRUARY 2021
More InfoThis study, carried out by a group of trainee interns at the University of Otago, surveyed key clinical leads in 18 District Health Boards (DHBs) in New Zealand, as well as members of the New Zealand Society for the Study of Diabetes (NZSSD) to determine what changes occurred in diabetes secondary services as a result of COVID-19, and what changes could be taken forward in the future. We thank the group for this helpful piece of work.
More InfoThe NZMJ have published an article prepared by the NZSSD executive
More Info
The COVID-19 pandemic has created significant concern for people with diabetes, here is some information regarding the specific risks for people with diabetes.
More InfoThis website uses cookies to ensure you get the best experience on our website.